Mankind Pharma Faces ₹2.27 Crore GST Penalty Over Alleged Reporting Discrepancies

Mankind Pharma is facing a ₹2.27 crore penalty for alleged discrepancies in its GST filings. The company reportedly made errors in reporting its GST liabilities, leading to non-compliance with tax laws. The GST authorities have imposed the penalty, citing significant discrepancies in the company’s financial reports. Mankind Pharma has the option to appeal the decision, but the penalty could impact its financial standing if upheld. This case highlights the importance of accurate and timely reporting under GST and serves as a reminder to businesses about the potential financial consequences of non-compliance with tax regulations.